Two-day-old chickens and mallards were orally inoculated with one of 5 doses varying from 2 x 10(2) to 2 x 10(6) of C. baileyi oocysts per individual. Generally, the more oocysts inoculated were, the longer the patent periods were, and the more oocysts shedding were. Meanwhile increasing the inoculative dose, the prepatent periods were shortened except that mallards inoculated with 2 x 10(2) and 2 x 10(3) oocysts failed to produce the oocysts. The more parasites involving oocysts appeared from the chicken in comparison to the mallard. In the chickens challenged with a single dose of 2 x 10(6) oocysts, a small number of oocysts were detected from feces on days 4-14 after challenge infection (ACI) in all of carrageenan administered groups and in the control groups inoculated with 2 x 10(2) and 2 x 10(3) oocysts. In the mallards, a few oocysts were also recognized on days 5-15 ACI in all of carrageenan treated groups and in the control groups inoculated with 2 x 10(2), 2 x 10(3) and 2 x 10(4) oocysts. Just prior to challenge infection, phagocytic activity of peritoneal macrophages (Mø) and the number of peripheral Mø in both birds were significantly decreased in the carrageenan treated groups as compared to the control groups. Mild challenge infection in both birds denoted that the immunogenicity of C. baileyi to the birds was very strong, despite Mø blocker carrageenan administration.
No takes yet. Share an insight, caveat, or question.
Rhee et al. (1995) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: